Impact of Intravenous Ferric Carboxymaltose on Quality of Life in Patients with Iron Deficiency Anemia: A Prospective Observational Study [PDF]
Rıfat Bozkuş, Emin Gemcioğlu, Şeyma Sarışen Department of Internal Medicine, Ankara Etlik City Hospital, Ankara, TurkeyCorrespondence: Rıfat Bozkuş, Department of ...
Bozkuş R, Gemcioğlu E, Sarışen Ş
doaj +2 more sources
Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function [PDF]
Background: Reduced kidney function is common among patients with heart failure. In patients with heart failure and/or kidney disease, iron deficiency is an independent predictor of adverse outcomes.
Jankowska, Ewa A +54 more
core +6 more sources
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [PDF]
Background: Iron deficiency may impair aerobic performance. This study aimed to determine whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in patients who had heart failure, reduced left ventricular ejection fraction,
Drexler, Helmut +17 more
core +3 more sources
Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease [PDF]
Background and Aims:We analyzed iron deficiency and the therapeutic response following intravenous ferric carboxymaltose in a large single-center inflammatory bowel disease (IBD) cohort.
Brand, Stephan +21 more
core +1 more source
Treatment of iron deficiency with intravenous ferric carboxymaltose in general practice: a retrospective database study. [PDF]
BACKGROUND Iron deficiency is a frequent problem in general practice. Oral supplementation may in some cases not be well tolerated or not be efficient.
Kuster, Martina, Meli, Damian N
core +2 more sources
Intravenous ferric carboxymaltose for anaemia in pregnancy [PDF]
Background: Iron deficiency is a common nutritional deficiency amongst women of childbearing age. Peri-partum iron deficiency anaemia (IDA) is associated with significant maternal, fetal and infant morbidity.
Hodyl, N.A. +7 more
core +2 more sources
Intravenous ferric carboxymaltose for anaemia in pregnancy [PDF]
Background: Anaemia in pregnancy is associated with unfavourable consequences both for the mother and the fetus and is a major cause of maternal and perinatal mortality and morbidity.Methods: The study was conducted over a period of one year in which 100
Gandotra, Nikita +2 more
core +1 more source
Adverse Reactions of Ferric Carboxymaltose [PDF]
The author reports a 55-year-old female diagnosed of chronic kidney disease grade-5 with associated co-morbidities like type 2 diabetes mellitus, diabetic retinopathy and hypothyroidism was admitted for arteriovenous fistula construction.
HARISH THANUSUBRAMANIAN +4 more
doaj +1 more source
Background and objective: Iron deficiency may impair aerobic performance. This study aimed to assess whether intravenous iron (ferric carboxymaltose) will improve symptoms in patients with heart failure with reduced left ventricular ejection fraction and
Hemn Ahmed Ismael +1 more
doaj +1 more source
A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anaemia during pregnancy [PDF]
Background: Iron deficiency anemia during pregnancy is a serious global concern specially in developing country, which is preventable with effective measures.
Patel, Alpesh R. +2 more
core +1 more source

